Medsenic is a private drug development company founded in 2010 and based in Paris.

Medsenic pioneers an exciting new therapeutic approach for the treatment of debilitating autoimmune diseases such as Systemic Lupus Erythematosus (SLE). The therapeutic approach may even apply to other autoimmune conditions and is clearly applicable to the Graft-versus-Host disease.


Localization : Paris, Strasbourg


FADiese 3, joined in 2016.03